A Rare Condition Survey

September 29, 2020

About this Survey
This survey is being conducted by The Mighty on behalf of a biopharmaceutical company. The purpose of the survey is to learn more about the experiences of patients and caregivers living with rare conditions. This survey is completely voluntary, and you can stop at any time. There are no right or wrong answers – just answer as accurately as you can.

What will happen during the research?
You will be asked to participate in an online survey about your experiences with a rare condition. This will take about 5-10 minutes to complete.

How will my information be used and protected?

  1. The Mighty will store and share data from this survey using encryption and password protection to carefully limit access to your data.
  2. De-identified data may be shared with the biopharmaceutical company behind this survey, and other education and advocacy initiatives. We will only share the responses you give in this survey. We will not share information that could identify you personally (such as name or email address).

What are the risks of participating?
Information you share will be used solely to help others better understand the experiences of those with a rare condition. The risk of participation is access to personal and confidential information.

What are the potential benefits of participating?
This survey does not provide treatment or medical advice of any kind. Therefore, there are no direct benefits to you. However, information learned may help other people better understand the challenges associated with rare conditions.

Questions about the research
You can read The Mighty’s full privacy policy here. If you have any questions about the policy or this survey, please reach out to research@themighty.com.

Start Survey

Related Posts

Register for the LADDER Database

Register for the LADDER Database

The Dup15q Alliance is excited to announce the launch of a new program designed to help advance research and clinical service for individuals living with Dup15q syndrome! Linking Angelman and Dup15q Databases for Expanded Research (LADDER) will allow information...

EEG Database

EEG Database

In order to support research of brain development and activity in as many dup15q syndrome patients as possible the Dup15q Alliance has created an electroencephalogram (EEG) and  magnetic resonance imaging (MRI) storage system that families can directly upload...

ARCADE and ENDYMION Studies

ARCADE and ENDYMION Studies

ARCADE Study   ARCADE is a Phase 2 open-label, signal-finding pilot study designed to inform the potential for future development of soticlestat in CDD and Dup15q. The study enrolled 20 patients, ages 2 to 55 years, with refractory epileptic seizures associated with...